Search results
Showing 481 to 495 of 1308 results for social care
Larotrectinib for treating NTRK fusion-positive advanced solid tumours (MA review of TA630) [ID6292]
In development Reference number: GID-TA11565 Expected publication date: 18 November 2026
In development Reference number: GID-TA11963 Expected publication date: 27 January 2027
In development Reference number: GID-TA11802 Expected publication date: TBC
Our forward view highlights the areas we will prioritise in the coming year.
This guideline covers how to identify adults at high risk of type 2 diabetes. It aims to remind practitioners that age is no barrier to being at high risk of, or developing, the condition. It also aims to help them provide those at high risk with an effective and appropriate intensive lifestyle-change programme to prevent or delay the onset of type 2 diabetes. The recommendations in this guideline can be used alongside the NHS Health Check programme .
In development Reference number: GID-TA11340 Expected publication date: TBC
In development Reference number: GID-TA11477 Expected publication date: 07 January 2027
This guideline covers how to create the right conditions for mental wellbeing at work. It aims to promote a supportive and inclusive work environment, including training and support for managers and helping people who have or are at risk of poor mental health.
This guidance evaluates digital technologies, diagnostics and medical devices (including artificial intelligence).
This guideline covers the organisation and provision of major trauma services in pre-hospital and hospital settings, including ambulance services, emergency departments, major trauma centres and trauma units. It aims to reduce deaths and disabilities in people with serious injuries by providing a systematic approach to the delivery of major trauma care. It does not cover services for people with burns.
Jobs at NICE. Includes current vacancies, roles, location and salary information.
Our board sets out our strategic priorities and policies. It has 2 sub-committees, the audit and risk assurance committee and the remuneration committee.
This process and methods guide has been developed to help guidance‑producing centres make research recommendations. It describes a step-by-step approach to identifying uncertainties, formulating research recommendations and research questions, prioritising them and communicating them to the NICE Science Policy and Research (SP&R) team, researchers, and funders
Resmetirom for treating non-alcoholic steatohepatitis and liver fibrosis [ID6529]: draft guidance
We are listening to your views on this Technology appraisal guidance. Comments close 30 June 2026.
Nivolumab with ipilimumab for untreated advanced hepatocellular carcinoma [ID6239]
In development Reference number: GID-TA11116 Expected publication date: 11 November 2026